ARVN Q2 2022 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$907M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$34M+514.5% YoY

Gross Profit

$32M94.4% margin

Operating Income

-$66M-194.7% margin

Net Income

-$70M-207.1% margin

EPS (Diluted)

$-1.32

QoQ Revenue Growth

+27.5%

Cash Flow

Operating Cash Flow

-$79M

Free Cash Flow

-$80M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$736M

Stockholders' Equity

$671M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$6M	+514.5%
Gross Profit	$32M	$6M	+480.0%
Operating Income	-$66M	-$52M	-26.8%
Net Income	-$70M	-$50M	-39.2%